4.5 Article

Associations between body composition, fat distribution and metabolic consequences of excess adiposity with severe COVID-19 outcomes: observational study and Mendelian randomisation analysis

Related references

Note: Only part of the references are listed.
Review Endocrinology & Metabolism

Global pandemics interconnected - obesity, impaired metabolic health and COVID-19

Norbert Stefan et al.

Summary: Obesity and impaired metabolic health are established risk factors for NCDs such as type 2 diabetes mellitus, cardiovascular disease, neurodegenerative diseases, cancer, and MAFLD, and have been linked to an increased risk of severe COVID-19. Specifically, visceral obesity and characteristics of impaired metabolic health are associated with a high risk of severe COVID-19.

NATURE REVIEWS ENDOCRINOLOGY (2021)

Article Cardiac & Cardiovascular Systems

Associations of Adiposity, Circulating Protein Biomarkers, and Risk of Major Vascular Diseases

Yuanjie Pang et al.

Summary: This subcohort study of 628 Chinese adults found that body mass index was positively associated with multiple protein biomarkers, some of which were also associated with the risk of cardiovascular disease. These findings suggest that proteins may partly explain the link between obesity and cardiovascular disease.

JAMA CARDIOLOGY (2021)

Review Endocrinology & Metabolism

The effect of the magnitude of weight loss on non-alcoholic fatty liver disease: A systematic review and meta-analysis

Dimitrios A. Koutoukidis et al.

Summary: Studies have shown that even modest weight loss can lead to clinically significant improvements in NAFLD, with greater weight loss associated with greater benefits. There is a dose-response relationship between weight loss and liver inflammation, steatosis, and resolution of NAFLD or NASH.

METABOLISM-CLINICAL AND EXPERIMENTAL (2021)

Article Medicine, General & Internal

Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19

Anthony C. Gordon et al.

Summary: Interleukin-6 receptor antagonists tocilizumab and sarilumab were found to improve outcomes, including survival, in critically ill patients with Covid-19 receiving organ support in ICUs according to an ongoing international trial. The efficacy of these treatments has been confirmed, with patients benefiting from the therapy.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Medicine, General & Internal

Cardiometabolic risk factors for COVID-19 susceptibility and severity: A Mendelian randomization analysis

Aaron Leong et al.

Summary: This study used Mendelian randomization analyses to test the causal relationship between 17 cardiometabolic diseases and traits with COVID-19 illness. The findings suggest that higher body mass index is associated with a higher risk of hospitalization for COVID-19, possibly mediated by obesity-related cardiometabolic diseases.

PLOS MEDICINE (2021)

Article Endocrinology & Metabolism

Impact of body composition on COVID-19 susceptibility and severity: A two-sample multivariable Mendelian randomization study

Dennis Freuer et al.

Summary: Recent studies found a causal impact of overall obesity on susceptibility and severity of COVID-19, while the impact of abdominal obesity was weaker and disappeared after adjustment for BMI.Obese individuals should be considered a high-risk group for COVID-19.

METABOLISM-CLINICAL AND EXPERIMENTAL (2021)

Article Mathematical & Computational Biology

Testing and correcting for weak and pleiotropic instruments in two-sample multivariable Mendelian randomization

Eleanor Sanderson et al.

Summary: The text introduces a new method for Multivariable Mendelian randomization (MVMR) to address challenges in estimating causal effects. This method uses a conditional F-statistic to test whether genetic variants strongly predict each exposure, allowing for reliable causal effect estimates in the presence of weak instruments and pleiotropy.

STATISTICS IN MEDICINE (2021)

Article Endocrinology & Metabolism

Associations between body-mass index and COVID-19 severity in 6.9 million people in England: a prospective, community-based, cohort study

Min Gao et al.

Summary: The study found that above a BMI of 23 kg/m(2), there is a linear increase in the risk of severe consequences of COVID-19 leading to hospital admission and death, and a linear increase in ICU admission risk across the entire BMI range. The impact of increasing BMI is particularly notable in individuals younger than 40 years and of Black ethnicity.

LANCET DIABETES & ENDOCRINOLOGY (2021)

Editorial Material Infectious Diseases

Who is most likely to be infected with SARS-CoV-2?

Rachel E. Jordan et al.

LANCET INFECTIOUS DISEASES (2020)

Article Endocrinology & Metabolism

Causes, consequences, and treatment of metabolically unhealthy fat distribution

Norbert Stefan

Lancet Diabetes & Endocrinology (2020)

Review Endocrinology & Metabolism

Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study

Emma Barron et al.

LANCET DIABETES & ENDOCRINOLOGY (2020)

Editorial Material Endocrinology & Metabolism

Outcomes of COVID-19: disparities in obesity and by ethnicity/race

Matthew J. Townsend et al.

INTERNATIONAL JOURNAL OF OBESITY (2020)

Article Endocrinology & Metabolism

Visceral fat shows the strongest association with the need of intensive care in patients with COVID-19

Mikiko Watanabe et al.

METABOLISM-CLINICAL AND EXPERIMENTAL (2020)

Letter Cardiac & Cardiovascular Systems

Cardiometabolic Traits, Sepsis, and Severe COVID-19 A Mendelian Randomization Investigation

Mark J. Ponsford et al.

CIRCULATION (2020)

Article Endocrinology & Metabolism

The role of visceral adiposity in the severity of COVID-19: Highlights from a unicenter cross-sectional pilot study in Germany

Antonia Petersen et al.

METABOLISM-CLINICAL AND EXPERIMENTAL (2020)

Article Multidisciplinary Sciences

Collider bias undermines our understanding of COVID-19 disease risk and severity

Gareth J. Griffith et al.

NATURE COMMUNICATIONS (2020)

Article Public, Environmental & Occupational Health

An examination of multivariable Mendelian randomization in the single-sample and two-sample summary data settings

Eleanor Sanderson et al.

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2019)

Article Public, Environmental & Occupational Health

Confounding by ill health in the observed association between BMI and mortality: evidence from the HUNT Study using offspring BMI as an instrument

David Carslake et al.

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2018)

Article Medicine, General & Internal

Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians

Neil M. Davies et al.

BMJ-BRITISH MEDICAL JOURNAL (2018)

Article Medicine, General & Internal

Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians

Neil M. Davies et al.

BMJ-BRITISH MEDICAL JOURNAL (2018)

Article Public, Environmental & Occupational Health

Comparison of Sociodemographic and Health-Related Characteristics of UK Biobank Participants With Those of the General Population

Anna Fry et al.

AMERICAN JOURNAL OF EPIDEMIOLOGY (2017)

Article Genetics & Heredity

Bias due to participant overlap in two-sample Mendelian randomization

Stephen Burgess et al.

GENETIC EPIDEMIOLOGY (2016)

Review Medicine, Research & Experimental

Insulin-like growth factor-1 deficiency and metabolic syndrome

G. A. Aguirre et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2016)

Article Medicine, General & Internal

Type 2 diabetes as a disease of ectopic fat?

Naveed Sattar et al.

BMC MEDICINE (2014)

Article Health Policy & Services

UK Biobank: Current status and what it means for epidemiology

Naomi Allen et al.

HEALTH POLICY AND TECHNOLOGY (2012)

Review Cardiac & Cardiovascular Systems

Ectopic Fat Depots and Cardiovascular Disease

Kathryn A. Britton et al.

CIRCULATION (2011)

Article Nutrition & Dietetics

Adiponectin in insulin resistance: lessons from translational research

Florencia Ziemke et al.

AMERICAN JOURNAL OF CLINICAL NUTRITION (2010)

Article Endocrinology & Metabolism

Intensive glucose control and macrovascular outcomes in type 2 diabetes

F. M. Turnbull et al.

DIABETOLOGIA (2009)

Article Endocrinology & Metabolism

Pathogenesis of type 2 diabetes: tracing the reverse route from cure to cause

R. Taylor

DIABETOLOGIA (2008)

Review Endocrinology & Metabolism

Review: The role of insulin resistance in nonalcoholic fatty liver disease

Kristina M. Utzschneider et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)